Share ownership AstraZeneca PLC

AZN

GB0009895292

Pharmaceuticals

Market Closed - London S.E. Other stock markets 11:35:09 2024-09-19 am EDT			5-day change	1st Jan Change
11,898.00 ^GBX	+0.35%		-3.33%	+12.25%

Sep. 18	European Equities Close Lower in Wednesday Trading; EU, Euro Area Inflation Declines in August	MT
Sep. 18	AstraZeneca Says US FDA Approves Fasenra for Rare Vasculitis Treatment	MT

Share class: AstraZeneca PLC

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	1,550,286,637	1,498,107,964 ( 96.63 %)	0	96.63 %

Major shareholders: AstraZeneca PLC

Name	Equities	%	Valuation
BlackRock Investment Management (UK) Ltd. 4.419 %	68,512,693	4.419 %	11 952 M p
Wellington Management Co. LLP 4.201 %	65,120,892	4.201 %	11 361 M p
The Vanguard Group, Inc. 3.691 %	57,216,000	3.691 %	9 982 M p
Investor AB (Investment Company) 3.328 %	51,587,810	3.328 %	9 000 M p
Norges Bank Investment Management 2.123 %	32,908,000	2.123 %	5 741 M p
BlackRock Fund Advisors 1.962 %	30,410,680	1.962 %	5 305 M p
Fidelity Management & Research Co. LLC 1.016 %	15,756,871	1.016 %	2 749 M p
SSgA Funds Management, Inc. 0.9849 %	15,268,000	0.9849 %	2 664 M p
Legal & General Investment Management Ltd. 0.9608 %	14,894,922	0.9608 %	2 598 M p
BlackRock Advisors LLC 0.9044 %	14,020,119	0.9044 %	2 446 M p
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Name	Equities	%	Valuation
T. Rowe Price International Ltd. 2.094 %	64,939,661	2.094 %	5 690 M p
PRIMECAP Management Co. 1.374 %	42,597,235	1.374 %	3 732 M p
Wellington Trust Co., NA 1.308 %	40,569,917	1.308 %	3 555 M p
Capital Research & Management Co. (International Investors) 1.184 %	36,703,718	1.184 %	3 216 M p
Fidelity Management & Research Co. LLC 0.7370 %	22,851,776	0.7370 %	2 002 M p
Fiduciary Trust Company International 0.5676 %	17,599,960	0.5676 %	1 542 M p
Jennison Associates LLC 0.5491 %	17,023,655	0.5491 %	1 492 M p
Merrill Lynch International 0.5143 %	15,945,156	0.5143 %	1 397 M p
Sanders Capital LLC 0.4820 %	14,945,242	0.4820 %	1 310 M p
The Ayco Co. LP 0.4030 %	12,496,350	0.4030 %	1 095 M p
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Name	Equities	%	Valuation
Caixa DTVM SA 0.002967 %	276,073	0.002967 %	4 M p
Daycoval Asset Management Administração de Recursos Ltda. 0.000029 %	2,657	0.000029 %	38 251 p

Breakdown by shareholder type

Institutional	50.72%
Other	2.07%
Governments	0.07%
Individuals	0.03%
Wärtsilä Oyj Abp	0.02%
Avolta AG	0.01%
Unknown	47.08%

Based on 1000 largest holdings

Geographical origin of shareholders

United States	20.93%
United Kingdom	16.97%
Sweden	4.43%
Norway	2.38%
Luxembourg	1.14%
Switzerland	1.07%
Japan	0.68%
France	0.65%
Singapore	0.61%
Germany	0.54%
Canada	0.54%
Netherlands	0.42%
Spain	0.29%
South Korea	0.29%
Bahamas	0.22%
Hong Kong	0.20%
Ireland	0.20%
Malaysia	0.19%
Italy	0.17%
Finland	0.16%
Denmark	0.16%
Kuwait	0.13%
Australia	0.11%
Belgium	0.06%
Thailand	0.05%
China	0.05%
United Arab Emirates	0.04%
Austria	0.04%
South Africa	0.03%
Individuals	0.03%
Czech Republic	0.03%
New Zealand	0.03%
Bermuda	0.02%
Slovenia	0.01%
Portugal	0.01%
Taiwan	0.01%

Based on 1000 largest holdings

AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (95.6%). Net sales break down by treatment area between oncology (39.2%), cardiovascular, renal and metabolic diseases (24.2%), respiratory and autoimmune diseases (13.9%), and other (22.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (4.4%). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (21.2%), America (45.3%) and Africa-Asia-Australia (26.1%).

Employees

89,900

Sector

Pharmaceuticals

Calendar

2024-09-24 - Bernstein Pharma Conference

More about the company